Research Topics

Genomes and Genes

Species

Sherri Ann M Burnett-Bowie

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. Burnett Bowie S, McKay E, Lee H, Leder B. Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels. J Clin Endocrinol Metab. 2009;94:4785-92 pubmed publisher
    ..In older men, aromatase inhibition increases testosterone levels, decreases estradiol levels, and appears to decrease BMD. Aromatase inhibition does not improve skeletal health in aging men with low or low normal testosterone levels. ..
  2. Burnett Bowie S, Leder B, Henao M, Baldwin C, Hayden D, Finkelstein J. Randomized trial assessing the effects of ergocalciferol administration on circulating FGF23. Clin J Am Soc Nephrol. 2012;7:624-31 pubmed publisher
    ..When measuring fibroblast growth factor 23, concurrent 25-hydroxyvitamin D measurements should be obtained, because vitamin D deficiency may lower circulating fibroblast growth factor 23 levels. ..

Detail Information

Publications2

  1. Burnett Bowie S, McKay E, Lee H, Leder B. Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels. J Clin Endocrinol Metab. 2009;94:4785-92 pubmed publisher
    ..In older men, aromatase inhibition increases testosterone levels, decreases estradiol levels, and appears to decrease BMD. Aromatase inhibition does not improve skeletal health in aging men with low or low normal testosterone levels. ..
  2. Burnett Bowie S, Leder B, Henao M, Baldwin C, Hayden D, Finkelstein J. Randomized trial assessing the effects of ergocalciferol administration on circulating FGF23. Clin J Am Soc Nephrol. 2012;7:624-31 pubmed publisher
    ..When measuring fibroblast growth factor 23, concurrent 25-hydroxyvitamin D measurements should be obtained, because vitamin D deficiency may lower circulating fibroblast growth factor 23 levels. ..